pharmaphorum

SEPTEMBER 3, 2020

King’s Cross is also home to Google’s DeepMind artificial intelligence company, which has already been involved in life sciences projects such as using the technology to predict acute kidney injury. The tech giant NVIDIA will also send a team of engineers to the building to explore ways of collaborating to discover new drugs.

Life Science 113

Life Science Engineer Scientist Pharma Companies 113

Pharmaceutical Technology

SEPTEMBER 16, 2022

A 2021 GlobalData poll among readers of Pharmaceutical Technology , found that 43% of respondents agreed environmental issues were the most important aspect of ESG that pharma companies needed to address.

Pharma Companies 130

Pharma Companies Production Manufacturing Vaccination 130

Drug Discovery World

OCTOBER 12, 2023

Our collaboration with BioMap further underscores Sanofi’s commitment to becoming the first pharma company powered by AI at scale.” The post Collaboration to develop AI modules for biotherapeutics appeared first on Drug Discovery World (DDW).

Development 52

Development Protein Life Science Pharma Companies 52

pharmaphorum

DECEMBER 1, 2022

Biotech / Pharma Companies – Investigative toxicologist, Research Scientist, Clinical Pharmacologist, Cell Technologists, Cell and Molecular Scientist, Head of Translational Research, In-Vitro Toxicologists, Director of Drug Discovery, Head of DMPK, Chief Scientific Officer, R&D Scientist, Head of R&D. Who Should Attend?

In-Vitro 52

In-Vitro Engineer Scientist Gene Therapy 52

Pharmaceutical Technology

JUNE 5, 2023

Pharma companies around the world have also faced similar threats , some of which have impacted national security and public health. Social engineering attacks will rise, in addition to phishing, smishing and deepfake attacks.

Compliance 276

Compliance Regulation Pharmacy Genome 276

pharmaphorum

MARCH 16, 2021

It’s one of the few AI drug discovery companies operating in the antibody category, as most are focused on small molecules. He said the company is already working with “major pharma companies” to apply its platform and get data to train its models.

Antibody 94

Antibody Bioavailability Engineer Drugs 94

pharmaphorum

JANUARY 18, 2022

Workshop Leader: Kenny Dalgarno, Professor of Manufacturing Engineering, Newcastle University. Biotech / Pharma Companies – Team Leader, Junior Principle investigator, Cell and Molecular Scientist, Chief Scientific Officer, Deputy Director, Manager, Founder, CEO, Head, Director, Programme Manager, Lab Head, Toxicologist.

In-Vitro 52

In-Vitro Engineer Drugs Pharma Companies 52

pharmaphorum

SEPTEMBER 20, 2022

The big pharma company is making a $20 million investment in the Israeli startup along with funding that could reach $90 million over the next five years, in a return for options to license CytoReason’s AI platform and disease models.

Pharma Companies 52

Pharma Companies Trials Engineer Development 52

pharmaphorum

DECEMBER 29, 2022

Digital transformation has many different aspects, of course, but it is possible to pick out the most important ways technology and automation can support pharma companies to mitigate increased complexity and help respond fast to challenges and opportunities in the years ahead. Crisis readiness and digital workflows.

Manufacturing 110

Manufacturing Medicine Pharma Companies Engineer 110

pharmaphorum

FEBRUARY 16, 2022

Feskens will join CEO and founder Matt Lowe and CCO, Jason Brown on the Global Executive Board and brings a broad experience from local and International commercial roles in large, mid-size and start up pharma companies.

Pharma Companies 52

Pharma Companies Marketing Engineer Production 52

pharmaphorum

NOVEMBER 23, 2021

Sanofi has bolstered its push into mRNA-based therapies with a new licensing deal – but not as might be expected with some up-and-coming biotech company. Sanofi is the first pharma company to partner with Baidu on its LinearDesign AI platform, which has been developed specifically to optimise the sequence of mRNA-based vaccines and drugs.

Licensing 105

Licensing Licensing Vaccination Vaccine 105

pharmaphorum

FEBRUARY 13, 2022

“It’s no wonder that 92% of drugs that are successful in mice are failing in clinical trials in humans,” he added, noting that collaborations with pharma companies like Merck be crucial for refining the use of the BioAI platform for clinical prediction.

Drugs 98

Drugs In-Vivo In-Vitro Pharma Companies 98

The Pharma Data

JANUARY 24, 2021

.–( BUSINESS WIRE )– Faze Medicines , a biotechnology company pioneering therapeutics based on the groundbreaking new science of biomolecular condensates, today announced that it has appointed Philip Vickers, Ph.D., Preclinical and clinical programs at Northern Biologics were acquired by big pharma companies in 2020.

Medicine 52

Medicine Pharma Companies Gene Therapy Development 52

pharmaphorum

DECEMBER 9, 2022

The PharmaStars accelerator was set up last year to help bridge the gap between digital health start-ups and potential pharma partners, which can be instrumental in making sure their technologies meet their potential – and help them to navigate the challenges of developing them in the highly regulated healthcare environment.

Life Science 52

Life Science DNA Genome Genomics 52

pharmaphorum

FEBRUARY 18, 2021

Researchers from the University of Texas Medical Branch based their findings on lab tests using SARS-CoV-2 coronaviruses that were genetically engineered to have the same mutations as those in the strain that is causing scientists so much concern.

Immune Response 52

Immune Response Genetic Engineering Vaccination Vaccine 52

pharmaphorum

MAY 12, 2021

Lilly’s head of new therapeutic modalities, Andrew Adams, said that saRNAs are “a promising new technology, which will expand the breadth of Lilly’s RNA therapeutics platform and the targets we can pursue” The US pharma company has been building a presence in RNA medicines via a series of partnerships, including a $1.2

RNA 64

RNA Protein Drugs Pharma Companies 64

Pharma Marketing Network

MARCH 29, 2022

With the pandemic and the shift to mobile devices, customers are demanding more convenient and seamless ways to interact with pharma companies. I feel like there’s a lot that we still need to understand and feed back into that engine,” Canlas said. The customer relationship that the reps have with the HCP is just so key.

Marketing 52

Marketing Pharma Companies Sales Life Science 52

pharmaphorum

FEBRUARY 24, 2022

Insilico announced in February of last year that they had identified and developed the molecule in less than 18 months, using the company’s target identification engine PandaOmics and its molecular generation engine Chemistry42. The company raised a $225 million Series C round last summer led by Warburg Pincus.

Trials 40

Trials Drugs Clinical Trials Clinical Trials 40

XTalks

MARCH 31, 2023

High-quality crystals grown in space give us a better understanding of how the molecules interact than is possible on Earth,” said Robert Garmise, associate director of material science and engineering at BMS in another news release from ISS Lab. “A

Protein 97

Protein Research Development Manufacturing 97

pharmaphorum

AUGUST 23, 2021

The vaccine may be a latecomer to the COVID-19 vaccine arsenal, but its approval signals the potential of DNA vaccines and is a boost to companies working in this space. The company also says that it can update the vaccine very easily to deal with mutations in the virus.

DNA 98

DNA Vaccination Vaccine Genetic Engineering 98

pharmaphorum

MARCH 18, 2021

Pharma companies and sales reps need to adapt to their customer behaviours to stay relevant”. Pharma companies and their sales reps need to adapt to their customer behaviours to stay relevant. He is a digital transformation leader with experience across different companies and industries. But it doesn’t stop there.

Sales 52

Sales Pharma Companies Engineer Life Science 52

pharmaphorum

AUGUST 4, 2020

However VivoPlex said that like many other medical device and pharma companies, it will wait until the capacity becomes available after the COVID-19 lockdown. Developed by the government and delivered by the British Business Bank, the Future Fund supports high potential innovative businesses in the UK currently affected by COVID-19.

Development 52

Development Production Pharma Companies Engineer 52

XTalks

AUGUST 17, 2020

Cue Biopharma is a Cambridge, Massachusetts-based clinical-stage biotechnology company that is focused on developing injectable immune biologics using its proprietary Immuno-STAT (Selective Targeting and Alteration of T cells) platform. Cell-Based Immunotherapy vs. Immune Biologics. cells, receptors) to treat disease.

Protein 98

Protein Engineer Immune Response In-Vivo 98

Drug Discovery World

FEBRUARY 6, 2024

Biopharma and biotech companies without these capabilities are keen to harness these technologies and the number of strategic partnerships with such companies is accelerating at an unprecedented rate. Digital tech is also helping researchers to find target candidates for some of the most challenging disease areas.

Marketing 69

Marketing Medicine Genome Genomics 69

Drug Discovery World

JANUARY 21, 2024

He will also explain the importance of this innovation as a way to mitigate the high failure rates in clinical trials, which historically see 92% of drugs fail despite passing animal tests, leading to significant financial and time losses in the industry (approximately $53 billion for pharma companies annually).

Protein 52

Protein Vaccination Vaccine Development 52

pharmaphorum

JANUARY 29, 2021

Since that discovery, a flurry of gene-editing focused biopharma companies have launched – including Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences and Mammoth Biosciences – and the first drug therapies based on the technology are now in human testing for diseases like cancer. billion in funding.

Gene Editing 145

Gene Editing Gene Gene Therapy In-Vivo 145

pharmaphorum

JANUARY 7, 2021

The company argues that its technology, based on specially engineered antibody fragments, can give an accurate map of T-cell activity, giving a more representative picture of how the tumour is responding to an immunotherapy.

Doctors 53

Doctors Doctor Immune Response Pharma Companies 53

Drug Discovery World

DECEMBER 27, 2023

In this episode, Kelland shares what she means by the ‘next pandemic’, the lessons learnt from the Covid-19 pandemic, and the role of global health organisations and pharma companies going forward. Listen here. Thereafter, the series featured Dr Michael Pace, Global & Strategic Feasibility Expert at Rho.

Clinical Trials 69

Clinical Trials Clinical Trials Drugs Development 69

pharmaphorum

FEBRUARY 11, 2022

Sun says because of this, Komodo engineered solutions or apps that “do certain things for end-users applied against the Healthcare Map.”. This technology can be particularly beneficial for rare disease organisations as they often don’t have data scientists at their disposal or full-stack engineers.

Life Science 104

Life Science Engineer Development Big Data 104

pharmaphorum

APRIL 1, 2021

HCP scores of a pharma company on relevance, trust, consistency and quality over time and overall experience? He is a digital transformation leader with experience across different companies and industries. He holds an MSc in Mechanical Engineering and has worked and lived in seven countries. About Exeevo.

Sales 74

Sales Marketing Life Science Pharma Companies 74

pharmaphorum

JUNE 10, 2022

Pharma’s evolving role in patient care. The digital revolution has already reshaped the commercial engine of biopharma companies. To compete now, companies need to own a larger portion of the treatment journey and the overall patient care experience. Partner to deliver at speed.

Marketing 133

Marketing Engineer Bioinformatics Regulation 133

pharmaphorum

MARCH 28, 2022

Built under a government tender, AION Labs comprises four large international pharma companies – AstraZeneca , Merck, Pfizer , and Teva – and another core partner, the Israel Biotech Fund. At times, companies invest millions of dollars in developing and studying a therapy that may find to be ineffective. The partnership.

Pharma Companies 98

Pharma Companies Antibody Protein Development 98

The Pharma Data

DECEMBER 9, 2020

Dave Villeneuve, President NexGen Analytics With 35+ years of experience, Dave holds an MBA and has held senior roles in IT, Operations and Engineering for mid-size and large Pharma Companies in Canada, including Apotex and Pharmascience. NexGen has primarily focused on the Life Sciences industry.

Life Science 52

Life Science Packaging Packaging Pharma Companies 52

pharmaphorum

JANUARY 5, 2023

Especially when searching for specialised positions, former employees are already familiar with company processes and are more quickly onboarded to fill immediate staffing needs. Prioritise professional development: With a scarcity of skilled labour, now is the time for pharma companies to tap into their greatest assets – their people.

Life Science 80

Life Science Pharmacy Marketing Sales 80

Pharmaceutical Technology

JUNE 14, 2023

The increase in demand for CPO services today and over the last decade is evidence of the added value that they offer to pharma companies both large and small, especially as drug developers seek to claim their share of the evolving ATMP market while overcoming complex challenges in its supply chain.

Contract Packaging 130

Contract Packaging Packaging Packaging Development 130

pharmaphorum

APRIL 26, 2022

At the same time, the pharma industry has also started to note the potential for a new treatment paradigm to be developed, and investment into the space has started to increase. More recent research has also suggested that there are links to the health of the heart and to the brain, through an impact on mental health.”.

Containment 115

Containment Development Production Immune Response 115

pharmaphorum

OCTOBER 12, 2020

on Bioprinting for 3D Cell Culture, led by Kenny Dalgarno, Professor of Manufacturing Engineering, Newcastle University. Workshop B – 13.30 – 17.30 The conference also provides insight about the latest technology advances allowing 3D bioprinting to revolutionize in vitro models.

In-Vitro 52

In-Vitro Development Pharma Companies Engineer 52